Mycoplasma pneumoniae and mucositis - Part of the Stevens-Johnson syndrome spectrum;Mycoplasma pneumoniae und Mukositis - Entität innerhalb des Spektrums des Stevens-Johnson-Syndroms

JDDG - Journal of the German Society of Dermatology

Volumn 10, Issue 10, 2012, Pages 740-745

  Meyer Sauteur, Patrick M ^a,b   Goetschel, Philippe ^a   Lautenschlager, Stephan ^a  

^a TRIEMLI HOSPITAL   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Erythema multiforme; Intravenous immunoglobulin; Mucositis; Mycoplasma pneumoniae; Stevens Johnson syndrome

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; IMMUNOGLOBULIN; MACROLIDE;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEVER; HUMAN; MUCOSA INFLAMMATION; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; ORAL MUCOSITIS; PATHOGENESIS; PROGNOSIS; SKIN DEFECT; STEVENS JOHNSON SYNDROME; TREATMENT FAILURE; UROGENITAL TRACT INFLAMMATION;

EID: 84867100208     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2012.07951.x     Document Type: Article

References (50)

1. Waites KB, Talkington DF,. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004; 17: 697-728. (Pubitemid 39372513)
2. Schalock PC, Dinulos JG,. Mycoplasma pneumoniae-induced cutaneous disease. Int J Dermatol 2009; 48: 673-680; quiz 680- 671.
3. Leaute-Labreze C, Lamireau T, Chawki D, Maleville J, Taieb A,. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child 2000; 83: 347-352.
4. Latsch K, Girschick HJ, Abele-Horn M,. Stevens-Johnson syndrome without skin lesions. J Med Microbiol 2007; 56: 1696-1699. (Pubitemid 350276524)
5. Hillebrand-Haverkort ME, Budding AE, bij de Vaate LA, van Agtmael MA,. Mycoplasma pneumoniae infection with incomplete Stevens-Johnson syndrome. Lancet Infect Dis 2008; 8: 586-587.
6. Ravin KA, Rappaport LD, Zuckerbraun NS, Wadowsky RM, Wald ER, Michaels MM,. Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome: a case series. Pediatrics 2007; 119: e1002-1005.
7. Meyer Sauteur PM, Gansser-Kalin U, Lautenschlager S, Goetschel P,. Fuchs syndrome associated with Mycoplasma pneumoniae (Stevens-Johnson syndrome without skin lesions). Pediatr Dermatol 2011; 28: 474-476.
8. Schalock PC, Dinulos JG,. "Atypical" Stevens-Johnson syndrome? Pediatrics 2007; 120: 451-452; author reply 452.
9. Schalock PC, Thyssen J, Dinulos JG,. Mycoplasma pneumoniae associated mucositis: by any other name is not so sweet. Pediatr Dermatol 2012; accepted.
10. Bressan S, Mion T, Andreola B, Bisogno G, Da Dalt L,. Severe Mycoplasma pneumoniae-associated mucositis treated with immunoglobulins. Acta Paediatr 2011; 100: e238-240.
11. McGouran DCR, Petterson T, McLaren JM, Wolbinski MP,. Mucositis, Conjunctivitis but no rash-The "Atypical Stevens-Johnson syndrome. Acute Medicine 2011; 10: 81-82.
12. Villarroel J, Bustamante MC, Denegri M, Perez L,. Manifestaciones muco-cutáneas de la infecciõn por Mycoplasma pneumoniae: Presentaciõn de cuatro casos. Rev Chilena Infectol 2009; 26: 457-463.
13. Artes Figueres M, Oltra Benavent M, Fernandez Calatayud A, Revert Gomar M,. Mucositis grave inducida por Mycoplasma pneumoniae. An Pediatr (Barc) 2009; 71: 573-574.
14. Havliza K, Jakob A, Rompel R,. Erythema multiforme majus (Fuchs syndrome) associated with Mycoplasma pneumoniae infection in two patients. J Dtsch Dermatol Ges 2009; 7: 445-448.
15. Figueira-Coelho J, Lourenco S, Pires AC, Mendonca P, Malhado JA,. Mycoplasma pneumoniae-associated mucositis with minimal skin manifestations. Am J Clin Dermatol 2008; 9: 399-403.
16. Walicka M, Majsterek M, Rakowska A, Slowinska M, Sicinska J, Goralska B, Ptasinska M, Rudnicka L, Marcinowska-Suchowierska E,. Mycoplasma pneumoniae-induced pneumonia with Stevens-Johnson syndrome of acute atypical course. Pol Arch Med Wewn 2008; 118: 449-453.
17. Sendi P, Graber P, Lepere F, Schiller P, Zimmerli W,. Mycoplasma pneumoniae infection complicated by severe mucocutaneous lesions. Lancet Infect Dis 2008; 8: 268. (Pubitemid 351391991)
18. Birch J, Chamlin S, Duerst R, Jacobsohn D,. Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome in a hematopoietic stem cell transplant recipient. Pediatr Blood Cancer 2008; 50: 1278-1279. (Pubitemid 351555561)
19. Fearon D, Hesketh EL, Mitchell AE, Grimwood K,. Mycoplasma pneumoniae infection complicated by pneumomediastinum and severe mucositis. J Paediatr Child Health 2007; 43: 403-405. (Pubitemid 46698309)
20. de Ru MH, Sukhai RN,. Stevens- Johnson syndrome. Eur J Pediatr 2007; 166: 1303-1304.
21. Zipitis CS, Thalange N,. Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations. Eur J Pediatr 2007; 166: 585-588. (Pubitemid 46643698)
22. Schalock PC, Dinulos JG, Pace N, Schwarzenberger K, Wenger JK,. Erythema multiforme due to Mycoplasma pneumoniae infection in two children. Pediatr Dermatol 2006; 23: 546-555. (Pubitemid 44800272)
23. Kim HS, Kim GM, Kim SY,. A case of Stevens-Johnson syndrome with subcorneal pustules associated with Mycoplasma pneumoniae infection. J Eur Acad Dermatol Venereol 2006; 20: 1353-1355. (Pubitemid 44614655)
24. Schalock PC, Dinulos JG,. Mycoplasma pneumoniae-induced Stevens-Johnson syndrome without skin lesions: fact or fiction? J Am Acad Dermatol 2005; 52: 312-315.
25. Kirke S, Powell FC,. Mucosal erosions and a cough. Ir Med J 2003; 96: 245.
26. Kagansky N, Malka A, Shmuel L, Jacob B, Zimhony O,. A 17-year-old patient with pulmonary infiltrate and rash. Clin Infect Dis 2003; 36: 188, 219-120.
27. Vanfleteren I, Van Gysel D, De Brandt C,. Stevens-Johnson syndrome: a diagnostic challenge in the absence of skin lesions. Pediatr Dermatol 2003; 20: 52-56. (Pubitemid 37047173)
28. Barfod TS, Pedersen C,. Svaer stomatit udlost af infektion med Mycoplasma pneumoniae. Ugeskr Laeger 1999; 161: 6363-6364.
29. Alter SJ, Stringer B,. Mycoplasma pneumoniae infections associated with severe mucositis. Clin Pediatr (Phila) 1990; 29: 602-604.
30. Lods F, Gramet C, Ghenassia C,. Mycoplasma pneumoniae et syndrome bulleuse des muqueuses. Bull Soc Ophtalmol Fr 1983; 83: 323-324.
31. Sieber OF, Jr., John TJ, Fulginiti VA, Overholt EC,. Stevens-Johnson syndrome associated with Mycoplasma pneumoniae infection. Jama 1967; 200: 79-81.
32. Lind K,. Mucocutaneous reactions during Mycoplasma pneumoniae infection. Lancet 1978; 1: 655.
33. Stevens AM, Johnson FC,. A new eruptive fever associated with stomatitis and ophthalmia. Am J Dis Child 1922; 24: 526-533.
34. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC,. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92-96. (Pubitemid 23029676)
35. Finkelstein Y, Soon GS, Acuna P, George M, Pope E, Ito S, Shear NH, Koren G, Shannon MW, Garcia-Bournissen F,. Recurrence and Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children. Pediatrics 2011; 128: 723-728.
36. Wetter DA, Camilleri MJ,. Clinical, etiologic, and histopathologic features of Stevens-Johnson syndrome during an 8-year period at Mayo Clinic. Mayo Clin Proc 2010; 85: 131-138.
37. Waris ME, Toikka P, Saarinen T, Nikkari S, Meurman O, Vainionpaa R, Mertsola J, Ruuskanen O,. Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol 1998; 36: 3155-3159. (Pubitemid 28476156)
38. Nadal D, Bossart W, Zucol F, Steiner F, Berger C, Lips U, Altwegg M,. Community-acquired pneumonia in children due to Mycoplasma pneumoniae: diagnostic performance of a seminested 16S rDNA-PCR. Diagn Microbiol Infect Dis 2001; 39: 15-19. (Pubitemid 32149950)
39. Cherry JD,. Anemia and mucocutaneous lesions due to Mycoplasma pneumoniae infections. Clin Infect Dis 1993; 17 Suppl 1: S47-51. (Pubitemid 23227105)
40. Narita M,. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J Infect Chemother 2010; 16: 162-169.
41. Narita M,. Pathogenesis of neurologic manifestations of Mycoplasma pneumoniae infection. Pediatr Neurol 2009; 41: 159-166.
42. Kusunoki S, Shiina M, Kanazawa I,. Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry. Neurology 2001; 57: 736-738. (Pubitemid 32783015)
43. Christie LJ, Honarmand S, Talkington DF, Gavali SS, Preas C, Pan CY, Yagi S, Glaser CA. Pediatric encephalitis: what is the role of Mycoplasma pneumoniae? Pediatrics 2007; 120: 305-313. (Pubitemid 47219500)
44. Mulholland S, Gavranich JB, Chang AB,. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev 2010; CD004875.
45. Barnes PJ, Adcock IM,. Glucocorticoid resistance in inflammatory diseases. Lancet 2009; 373: 1905-1917.
46. Kazatchkine MD, Kaveri SV,. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001; 345: 747-755.
47. Metry DW, Jung P, Levy ML,. Use of intravenous immunoglobulin in children with stevens-johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature. Pediatrics 2003; 112: 1430-1436. (Pubitemid 37523435)
48. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE,. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282: 490-493. (Pubitemid 28483679)
49. Fukiwake N, Moroi Y, Urabe K, Ishii N, Hashimoto T, Furue M,. Detection of autoantibodies to desmoplakin in a patient with oral erythema multiforme. Eur J Dermatol 2007; 17: 238-241. (Pubitemid 46847789)
50. Burch JM, Weston WL,. Erythema Multiforme, Stevens-Johnson-Syndrome and Toxic Epidermal Necrolysis. In: Textbook of Pediatric Dermatology. Eds., J. Harper, A. Oranje, N. Prose,. Blackwell Publishing 2nd ed. 2006, chapter 9.5: 740-754.